Neuroprotective effects of huperzine A: New therapeutic targets for neurodegenerative disease

Zhang, Hai Yan, Tang, Xi Can·2006·Trends in Pharmacological Sciences
DOI 10.1016/j.tips.2006.10.004

Cited by (174)

Items 101–174 of 174

  1. Huperzine A derivative M3 protects PC12 cells against sodium nitroprusside-induced apoptosis
    Na Ning, Jinfeng Hu, Yu‐He Yuan, Xinyuan Zhang, Jun-gui Dai, Nai‐Hong Chen · 2011 · Acta Pharmacologica Sinica
  2. Inhibiting β-Amyloid-Associated Alzheimer’s Pathogenesis In Vitro and In Vivo by a Multifunctional Dimeric Bis(12)-hupyridone Derived from Its Natural Analogue
    Shengquan Hu, Rui Wang, Wei Cui, Zaijun Zhang, Shinghung Mak, Daping Xu, Chung‐Lit Choi, Karl Wah Keung Tsim, Paul R. Carlier, Mingyuen Lee et al. · 2014 · Journal of Molecular Neuroscience
  3. Neuroprotective potential of Cucurbita maxima Duchesne ex Poir, Caeselpenia bunduc (L.) Roxb and Bombax ceiba Linn extracts
    Sonal Sinha, Brijesh Kumar, Suaib Luqman, Deepika Singh · 2018 · South African Journal of Botany
  4. Can food-derived multipotent agents reduce the risk of Alzheimer's disease
    Hongyu Zhang · 2007 · Trends in Food Science & Technology
  5. Natural alkaloids with therapeutic potential against Alzheimer's disease through cholinesterase inhibition
    Umam Khan, Mafaz Ahmad, Mariam Tuba, Raabia Naaz, Fayeqa Qayyum, Shahnaaz Khatoon, Sanobar, Shakir Ahamad, Mohammad Saquib, Mohd Kamil Hussain · 2025 · European Journal of Medicinal Chemistry
  6. The Use of Polyphenols for the Treatment of Alzheimer’s Disease
    Sethuraman Sathya, Kasi Pandima Devi · 2018 · Elsevier eBooks
  7. Exploring Potential of Alkaloidal Phytochemicals Targeting Neuroinflammatory Signaling of Alzheimer's Disease
    Md. Sahab Uddin, Md. Tanvir Kabir, Abdullah Al Mamun, Tapan Behl, Rasha Abdulrashed Mansouri, Akram Ahmed Aloqbi, Asma Perveen, Abdul Hafeez, Ghulam Md Ashraf · 2020 · Current Pharmaceutical Design
  8. The complete mitochondrial genome of huperzine A-producing endophytic fungus Penicillium polonicum
    Xincong Kang, Chichuan Liu, Dongbo Liu, Lu Zeng, Qianqian Shi, Kun Qian, Bingyan Xie · 2016 · Mitochondrial DNA Part B
  9. Alkaloids and Drug Discovery for Neurodegenerative Diseases
    Melanie‐Jayne R. Howes · 2013 · Springer eBooks
  10. Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis
    Wei Zheng, Ying‐Qiang Xiang, Xianbin Li, Gabor Sandor Ungvari, Helen F.K. Chiu, Feng Sun, Carl D’Arcy, Xiangfei Meng, Yu-Tao Xiang · 2016 · Human Psychopharmacology Clinical and Experimental
  11. Potent effects of alkaloid-rich extract from Huperzia selago against sodium nitroprusside-evoked PC12 cells damage via attenuation of oxidative stress and apoptosis
    Anna M. Lenkiewicz, Grzegorz Arkadiusz Czapski, Henryk M. Jęśko, Anna Wilkaniec, Wojciech J. Szypuła, Agnieszka Pietrosiuk, Aneta Marta Uszyńska, Agata Adamczyk · 2016 · Folia Neuropathologica
  12. Tacrine(10)-hupyridone, a dual-binding acetylcholinesterase inhibitor, potently attenuates scopolamine-induced impairments of cognition in mice
    Huixin Chen, Siying Xiang, Ling Huang, Jiajia Lin, Shengquan Hu, Shinghung Mak, Chuang Wang, Qinwen Wang, Wei Cui, Yifan Han · 2018 · Metabolic Brain Disease
  13. Structural analogs of huperzine A improve survival in guinea pigs exposed to soman
    Hendra Gunosewoyo, Suresh Kumar Tipparaju, Marco Pieroni, Ying Wang, Bhupendra P. Doctor, Madhusoodana P. Nambiar, Alan P. Kozikowski · 2012 · Bioorganic & Medicinal Chemistry Letters
  14. Huperzine A for treatment of cognitive impairment in major depressive disorder: a systematic review of randomized controlled trials.
    Wei Zheng, Ying‐Qiang Xiang, Gabor Sandor Ungvari, Fung Kum Helen Chiu, Chee H. Ng, Ying Wang, Yu‐Tao Xiang · 2016 · PubMed Central
  15. Determination of huperzine a inHuperzia selagoplants from wild population and obtained inin vitroculture by high-performance liquid chromatography using a chaotropic mobile phase
    Wojciech J. Szypuła, Anna Karolina Kiss, Agnieszka Pietrosiuk, Małgorzata Świst, Witold Danikiewicz, Olga Olszowska · 2011 · Acta Chromatographica
  16. Development of HuperTacrines as Non-Toxic, Cholinesterase Inhibitors for the Potential Treatment of Alzheimer’s Disease
    Mourad Chioua, Marta Pérez, Óscar M. Bautista‐Aguilera, Matilde Yáñez, Manuela G. López, Alejandro Romero, Ramón Cacabelos, Raimon Puig de la Bellacasa, Simone Brogi, Stefania Butini et al. · 2015 · Mini-Reviews in Medicinal Chemistry
  17. Therapeutic implications of anti-inflammatory natural products in Alzheimer’s disease
    Satarupa Deb, Muhammed Khairujjaman Mazumder, Ankumoni Dutta, Banashree Chetia Phukan, Pallab Bhattacharya, Rajib Kumar Paul, Anupom Borah · 2019 · Elsevier eBooks
  18. Toxicological scoring of Alzheimer’s disease drug huperzine in a guinea pig model
    Miroslav Pohanka, Filip Zemek, Hana Banďouchová, Jiří Pikula · 2011 · Toxicology Mechanisms and Methods
  19. Huperzine A for vascular dementia
    Zilong Hao, Ming Liu, Zhiqin Liu, Donghao Lv · 2008 · Cochrane Database of Systematic Reviews
  20. Poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate)-based microspheres as a sustained platform for Huperzine A delivery for alzheimer's disease therapy
    Dai‐Xu Wei, Duanfang Cai, Youguo Tan, Kezhi Liu, Jin‐Wei Dao, Xiang Li, Aikeremujiang Muheremu · 2024 · International Journal of Biological Macromolecules
  21. Synthesis of Novel 7-Phenyl-2,3-Dihydropyrrolo[2,1-b]Quinazolin-9(1H)-ones as Cholinesterase Inhibitors Targeting Alzheimer’s Disease Through Suzuki–Miyaura Cross-Coupling Reaction
    Davron Turgunov, Lifei Nie, Azizbek Nasrullaev, Zarifa Murtazaeva, Bianlin Wang, Dilafruz K. Kholmurodova, Rustamkhon Kuryazov, Jiangyu Zhao, Khurshed A. Bozorov, Haji Akber Aisa · 2025 · Molecules
  22. In silico identification of potential protein kinase C alpha inhibitors from phytochemicals from IMPPAT database for anticancer therapeutics: a virtual screening approach
    Saad Ali Alshehri, Shadma Wahab, Mohammad Ali Abdullah Almoyad · 2023 · Journal of Biomolecular Structure and Dynamics
  23. Alpinia Oxyphylla Miquel Fruit Extract Activates MAPK-mediated Signaling of PAs and MMP2/9 to Induce Schwann Cell Migration and Nerve Regeneration
    Yung‐Ming Chang, Chi-Xin Ye, Tsung‐Jung Ho, Te-Neng Tsai, Ping‐Ling Chiu, Chin‐Chuan Tsai, Yueh-Min Lin, Chia‐Hua Kuo, Fuu‐Jen Tsai, Chang‐Hai Tsai et al. · 2014 · The International Journal of Artificial Organs
  24. Boosting the autophagy‐lysosomal pathway by phytochemicals: A potential therapeutic strategy against Alzheimer's disease
    Fahimeh Nourbakhsh, Morgayn I. Read, George Emilio Barreto, Amirhossein Sahebkar · 2020 · IUBMB Life
  25. Huperzine A inhibits immediate addictive behavior but not behavioral sensitization following repeated morphine administration in rats
    Jinling Sun, Lin Tian, Ruisi Cui, Xinwang Li · 2017 · Experimental and Therapeutic Medicine
  26. Neuroprotective Effect of Huperzine A on d -Galactose-Induced Hearing Dysfunction
    Cong Li, Song Shi · 2019 · Ear Nose & Throat Journal
  27. Anticholinesterase activity and identification of huperzine A in three Mexican lycopods: Huperzia cuernavacensis, Huperzia dichotoma and Huperzia linifolia (Lycopodiaceae).
    Mariana Vázquez García, Gilsane Lino von Poser, Miriam Anders Apel, Rosa Cerros‐Tlatilpa, Aniceto Mendoza‐Ruiz, Marı́a Luisa Villarreal, Amélia Teresinha Henriques, Alexandre Cardoso-Taketa · 2017 · PubMed
  28. Novel use of probiotic as acetylcholine esterase inhibitor and a new strategy for activity optimization as a biotherapeutic agent
    Abdulrahman M. Qadah, Amr A. El-Waseif, Heba Yehia · 2023 · Journal of Applied Biology & Biotechnology
  29. Phytocompounds and lipid-based drug delivery system for neurodegenerative diseases
    Cennet Özay, Merve Karpuz · 2024 · Asian Pacific Journal of Tropical Biomedicine
  30. Potential Anti-Dementia Agents in Traditional Chinese Medicine
    Xuejuan Li, Hongyu Zhang · 2009 · Natural Product Communications
  31. Phytotherapy and the new paradigm of drugs mode of action.
    Elaine Elisabetsky · 2007 · Scientia et technica
  32. Design, synthesis, and preliminary biological evaluation of catalpol propionates as antiaging drugs
    Chunhong Dong, Shuanglin Liu, Xiaodong Cheng, Qiang Wang, Shiqing Jiang, Guoqing Wang · 2019 · BMC Chemistry
  33. Modulation of the Aβ-Peptide-Aggregation Pathway by Active Compounds From Platycladus orientalis Seed Extract in Alzheimer’s Disease Models
    Yan Li, Xiang Ming He, Yufan Jin, Jiawei Wang, Fengying Liang, Rongrong Pei, Peibo Li, Yonggang Wang, Weiwei Su · 2020 · Frontiers in Aging Neuroscience
  34. Drug Treatment Attenuates Retinal Ganglion Cell Death by Inhibiting Collapsin Response Mediator Protein 2 Phosphorylation in Mouse Models of Normal Tension Glaucoma
    Yuebing Wang, Musukha Mala Brahma, Kazuya Takahashi, Alessandra Nolia Blanco Hernandez, K. Ichikawa, Syuntaro Minami, Yoshio Goshima, Takayuki Harada, Toshio Ohshima · 2024 · NeuroMolecular Medicine
  35. Traditional Chinese herbal medicine for vascular dementia
    Edwin SY Chan, Dianne Bautista, Yong You, Jian Ting Long, Lu Ling, Wenyun Li, Christopher Chen · 2013 · Cochrane Database of Systematic Reviews
  36. Pteris laeta Wall. and Its New Phytochemical, Pterosinsade A, Promote Hippocampal Neurogenesis via Activating the Wnt Signaling Pathway.
    Yu-Sheng Shi, Ji-cong Chen, Bi-Hui Lin, Ruohan Wang, Jie Zhao, Sheng Li, Yan Zhang, Xu-Fu Zhang · 2023 · Journal of Agricultural and Food Chemistry
  37. In Silico Analysis to Link Insulin Resistance, Obesity and Ageing with Alzheimer’s Disease
    Priyanka Airen Sarkar, Premkumar Jayaraj, Ketaki Patwardhan, Samiksha Yeole, Sourajit Das, Yash Somaiya, Rajagopal Desikan, Kavitha Thirumurugan · 2021 · Journal of Molecular Neuroscience
  38. Pterosin sesquiterpenes and lignans from Pteris laeta Wall. and their neuroprotective bioactivity
    Yan Zhang, Chunbin Li, Haishun Xu, Bi-Hui Lin, Jicong Chen, Yu‐Meng Zhao, Jingxian Yang, Xu-Fu Zhang, Yu-Sheng Shi · 2022 · Journal of Molecular Structure
  39. Phlenumdines A−C, New Lycopodium Alkaloids Isolated from Phlegmariurus nummulariifolius
    Kan’ichiro Ishiuchi, Waka Nakayama, Orawan Monthakantirat, Kazumi Fujikawa, Santi Watthana, Susumu Kitanaka · 2017 · Heterocycles
  40. Huperzine A for mild cognitive impairment
    Jirong Yue, Bi Rong Dong, Xiufang Lin, Ming Jen Yang, Hong Mei Wu, Taixiang Wu · 2010 · Cochrane Database of Systematic Reviews
  41. Balanites aegyptiaca extract to treat risk factors of Alzheimer’s disease: an in vitro study
    Abeer Yousry Ibrahim, Samah Ali El-Newary, Saber Hendawy, Ahmed El-Gohary Ibrahim · 2020 · Egyptian Journal of Chemistry
  42. The promising role of bioactive congeners present in Cassytha filiformis in Alzheimer's disease: An explicative review
    Rakhi Khabiya, Dipanjan Karati, Sangeeta Dwivedi, Akanksha Dwivedi, Swarupananda Mukherjee · 2024 · Brain Disorders
  43. Mechanistic investigation on the performance of Huperzine A loaded microparticles based on ultra-fine particle processing system
    Tingting Peng, Peipei Yang, Chune Zhu, Xuejuan Zhang, Xinyi Wang, Hao Ran, Xuequn Bai, Jiwen Zhang, Chuan‐Yu Wu, Xin Pan et al. · 2017 · Powder Technology
  44. Exploring the molecular mechanisms of huperzine a in the treatment of rosacea through network pharmacology, machine learning, and molecular dynamics simulations
    Xin Luo, Su-han Yang, Lian Zhong, Peng Zhang · 2025 · Frontiers in Pharmacology
  45. Curcumin and Neurological/Brain Disorders
    Federico Franceschi, Stefano Togni, Giovanni Appendino · 2014 · Elsevier eBooks
  46. 5‐Amino‐6,7,8,9‐Tetrahydrobenzo[ b ][1,8]Naphthyridin‐2(1 H )‐One: The first Example of a new Family of HuperTacrines for Alzheimer's Disease Therapy
    Alba Balmori, Mourad Chioua, Raimon Puig de la Bellacasa, Roger Estrada‐Tejedor, Lhassane Ismaïli, Jose Luis Marco, José Ignacio Borrell · 2017 · ChemistrySelect
  47. Inflammasome-Mediated Inflammation in Neurodegenerative Diseases
    Jun Young Park, Yeo Wool Kang, Won Gil Cho · 2019 · The Open Neurology Journal
  48. Progress in the development of new drugs in Alzheimer’s disease
    Antoine Piau, Fati Nourhashémi, Christophe Hein, Céline Caillaud, Bruno J. Vellas · 2010 · The journal of nutrition health & aging
  49. Studies of Natural Products on Treating Neurological Disorders in China
    Haiyan Zhang, Xi Can Tang · 2007 · Cellular and Molecular Neurobiology
  50. Neuroprotective Potential of Small Molecule Phytochemicals in Stroke Therapy
    Sumedha Mukherjee, Amit Kumar Tripathi, Gaurav Kumar, Ranjana Patnaik, Nirav Dhanesha, Divya Mishra · 2019 · Springer eBooks
  51. Phytoconstituents Ameliorates Alzheimer's Disease and Cognitive Impairments: A Review of Preclinical Studies
    Vishal Kumar Biswkarma, Swati Wadhawan · 2024 · Current Bioactive Compounds
  52. Advances in the Treatment of Alzheimer's Disease
    Michael S. Rafii · 2012 · Wiley eBooks
  53. Bis(12)-Hupyridone, a Promising Multi-Functional Anti-Alzheimer’s Dimer Derived from Chinese Medicine
    Wei Cui, Tony Chunglit Choi, Shinghung Mak, Hua Yu, Shengquan Hu, Wenming Li, Zhong Zuo, Yifan H · 2012 · InTech eBooks
  54. Role of Phytoconstituents
    R. Prakash · 2023 · Advances in medical diagnosis, treatment, and care (AMDTC) book series
  55. Neuroprotective effect of dietary polyphenols
    Suchitra Nishal, Monika Gulia, Anil Kumar Sharma, Vikas Jhawat · 2024 · Elsevier eBooks
  56. Comparing Acetylcholinesterase and Butyrylcholinesterase Inhibition Effect of Total Extract and Fractions with Alcaloid-Rich Extract of Huperzia Serrata (Thunb.) Trevis.
    Hoai Thi Thu Nguyen, Nguyễn Thùy Dương, Bùi Thanh Tùng, Dao Thi Vui, Dang Kim Thu · 2020 · VNU Journal of Science Medical and Pharmaceutical Sciences
  57. The Effect of Alkaloid Extracted from Huperzia Phlegmaria on Cognitive Deficits Scopolamine-Induced in Mice
    Dang Kim Thu, Dao Thi Vui, Nguyen Thi Ngoc Huyen, Nguyễn Thị Thanh Bình, Nguyen Thi Huyen, Nguyễn Thị Yên, Bùi Thanh Tùng · 2020 · Current Bioactive Compounds
  58. Drug Development and Alzheimer's Disease
    Julien Delrieu, Antoine Piau, Bruno J. Vellas · 2012 · Wiley eBooks
  59. A “Magic Shotgun” Perspective on Anticonvulsant Mechanisms
    Matt Travis Bianchi, Kathy Chuang · 2012
  60. Conformational Flexibility and the Interaction of Huperzine A in the Active Site of Acetylcholinesterase: A Quantum Chemical and Charge Density Study
    Renuga Parameswari Azhagesan, Saravanan Kandasamy, P. Kumaradhas · 2016 · Preprints.org
  61. Assessment of In-House Natural Product and Synthetic Compound Libraries Based on In vitro Inhibition of Cholinesterases
    Päivi P. Järvinen · 2011 · Työväentutkimus Vuosikirja
  62. Managing Memory Impairment in Patients With Alzheimer’s Disease
    Aleksandra C. Stark, Andrew E. Budson · 2012 · Neurodegenerative Disease Management
  63. Chinese Herbal Medicine: Perspectives on Age-Related Neurodegenerative Diseases
    Khaled Radad, Rudolf Moldzio, Liu Lin-lin, Wolf‐Dieter Rausch · 2010 · Annals of traditional chinese medicine
  64. Strategies for the potential treatment of neurological disorders with Chinese and Indian medicinal plants
    A. A. Farooqui · 2020 · Elsevier eBooks
  65. Emerging evolution trends of application of natural products in Alzheimer’s disease
    Xuemei Wang, Xueli Li, Lin Zhang, Ruirui Guo, Xinyue Sun, Rui Xue Sun, Zexin Li, Lanlin Wang, Changwu Yue, Yuhong Lyu · 2021 · Journal of Computational Methods in Sciences and Engineering
  66. Drug development and Alzheimer's disease
    Julien Delrieu, Bruno J. Vellas · 2022 · Wiley eBooks
  67. Aloe Vera’s Effect on Acetyl Cholinesterase(AChE) and Ultra Structure of Motoneurons in Synaptic Zone After Spinal Cord Injury in Rats
    Marjan Heshmati, Mohammad Reza Jalali, Nadoushan Nadoushan, Maryam Sharayeli · 2016 · Biosciences Biotechnology Research Asia
  68. Identification of priority genes involved in ADHD using multiple system biology approach and establishment of Asiatic acid as a natural inhibitor against GRIN2B receptor
    Ananya Singh, Prekshi Garg, Prachi Srivastava · 2023 · Informatics in Medicine Unlocked
  69. Donepezil to lecanemab-advancements in targeted therapy of Alzheimer’s disease so far
    Fouqia Mahnaz Khanam · 2023 · International Journal of Advances in Medicine
  70. From Traditional Medicine to Modern Drug Development: Natural Products Targeting Amyloid Plaque in Alzheimer's Disease
    2023 · Biomedical Science and Clinical Research
  71. An Updated Review of Amyloid Beta Oligomer Toxicity Inhibition and Detection for Alzheimer's Disease Diagnosis
    Muhammad Jehangir, Rahman Ali, Wang Xiao Hui, Yifeng Wang · 2024 · Cognizance Journal of Multidisciplinary Studies
  72. Research Trends and Mechanistic Insights Into Natural Medicines for Alzheimer's Disease: A Bibliometric Analysis and Narrative Review
    Maoning Wang, Xiaolian Zhang, Huaxian Yang, Jianhe Zhao, Wentao Wei, Qian Zhao, Wenjia Wang, Yunhui Hu, Jiansong Fang · 2026 · Phytotherapy Research
  73. BindingDB Entry 50042721: Structural analogs of huperzine A improve survival in guinea pigs exposed to soman.
    BindingDB · 2013 · UC San Diego
  74. BindingDB Entry 50002994: Identification of Lycopodium Alkaloids Produced by an Ultraviolet-Irradiated Strain of Paraboeremia, an Endophytic Fungus from Lycopodium serratum var. longipetiolatum.
    BindingDB · 2020 · UC San Diego